Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Multimodal oncosurgery approach to treat peritoneal carcinomatosis in a patient with occlusive ovarian carcinoma
B. Moldovan1,*, F. Pescaru2, D. Pocreaţă Pocreaţă1, P. Biriş Biriş3, A. Moldovan4, M.E. CăpÎlna CăpÎlna5
1 General Surgery Department, "Sf.Constantin" Hospital, Braşov, Romania
2 Oncology Department, "Sf.Constantin" Hospital, Braşov, Romania
3 "Regina Maria" Diagnostic and Imagistics Centre, Braşov, Romania
4 Department of Infectious Diseases, "Sf.Constantin" Hospital, Braşov, Romania
5 1st Obstetrics and Gynaecology Clinic, Targu-Mureş, Romania
Eur. J. Gynaecol. Oncol. 2016, 37(2), 251–253; https://doi.org/10.12892/ejgo2806.2016
Published: 10 April 2016
Background: This paper aims to present a "pattern" of oncosurgery solution in a case generally considered unrecoverable: intestinal occlusion in case of ovarian carcinoma and carcinomatosis. Case Report: A 62-year-old female patient with ascites, carcinomatosis, unresectable pelvic tumour, and intestinal obstruction suffered a five-step oncosurgery "model": three surgical interventions overlapping chemotherapy administered via the systemic and intraperitoneal route: Step 1: colostomy and partial omentectomy; Step 2: five courses of systemic chemotherapy supported by granulocyte colony-stimulating factor; Step 3: radical surgery - total hysterectomy, bilateral adnexectomy, pelvic lymphadenectomy, omentectomy, appendectomy, pelvic peritonectomy, and hyperthermic intraperitoneal chemotherapy; Step 4: consolidation systemic chemotherapy consisting of three more similar cycles; Step 5: closure of the colostomy. Nine months after the beginning of treatment, the patient is with no evidence of disease. Conclusions: The association of surgical and oncologic treatment and the use of hyperthermic intraperitoneal chemotherapy (HIPEC) technology can solve some of these complex cases.
Occlusive ovarian cancer
Hyperthermic intraperitoneal chemotherapy